1Velho G, Erlich D, Turpin E,et al. Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care, 1993,16(5):742
2Joven J, Viella E. Serum levels of lipoprotein(a)in patients with well controlled non-insulin-dependent diabetes mellitus. JAMA,1991, 265(9):1 113
3Haffner S,Moss S, Klein B,et al.Lack of association between Lp(a)concentrations and coronary heart disease mortality in diabetes:the Wisconsin Epidemiologic Study of Diabetic Retinopathy.Metabolism,1992, 41(2):194
4Cressman MD,Heyka KJ,Paganini EP,et al. Lipoprotein(a) is an independent risk factor cardiovascular disease in hemodialysis patients.Circulation,1992, 86(12):475
5Oparil S, Oberman A.Nontraditional cardiovascular risk factors. Am J Med Sci,1999,317(3):193
5Jovin I S, Muller Berghaus G. Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis[J]. Atherosclerosis, 2004, 174(2): 225-233.
6Rahmani M, Raiszadeh F, Allahverdian S, et al. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects[J]. Atherosclerosis, 2002, 162(2): 381 -389.
7Havel R J, Rapaport E. Management of primary hyperlipidemia[J]. N Engl J Med, 1995, 332(22): 1491 -1498.
8Seljeflot I, Tonstad S, Hjermann I, et al. Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease[J]. Thromb Res, 2002, 105(4): 285 -290.
9Blum A, Lang N, Vigder F, et al. Effects of soy protein on endothelium-dependent vasodilatation and lipid profile in postmenopausal women with mild hypercholesterolemia[J]. Clin Invest Med, 2003, 26 (1):20 - 26.
10Asztalos BF,Roheim PS,Milani RL,et al.Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease[J].Arterioscler Thromb Vasc Biol,2000,20(12):2670-2676.
